Mandel Bencard Allergie

Almond, the active ingredient in Mandel Bencard Allergie, is an allergen extract presented as an intraepidermal allergen extract for intraepidermal use. It is employed to diagnose almond (Prunus dulcis) allergy by provoking a localized IgE‑mediated skin response in individuals suspected of hypersensitivity.

GNH USA supplies Mandel Bencard Allergie as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from comprehensive regulatory support and consistent product availability across multiple markets.

Mandel Bencard Allergie is used in allergy diagnostics to assess IgE‑mediated hypersensitivity to almond.

Almond allergy diagnosis: enables identification of IgE‑mediated sensitivity to almond proteins. Almond allergy work‑up: assists clinicians in differentiating almond allergy from other nut sensitivities. Pre‑operative assessment: helps determine risk before procedures involving almond‑containing products.

Administration of Mandel Bencard Allergie may be associated with local and systemic reactions.

Common Side Effects: - Redness at the test site - Mild swelling (wheal) - Itching or pruritus - Transient local discomfort

Serious or Rare Side Effects: - Systemic anaphylaxis - Severe bronchospasm - Angioedema

When using Mandel Bencard Allergie, clinicians should follow specific safety measures.

Patient selection: assess history of severe allergic reactions before testing. Test site preparation: ensure skin is clean and free of irritants. Observation period: monitor patient for at least 30 minutes after administration. Rescue medication: have epinephrine and antihistamines readily available. Contraindications: avoid use in patients with known severe almond allergy or uncontrolled asthma. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mandel Bencard Allergie may interact with certain medications that affect allergic responses.

Major Interactions (Avoid): - Systemic antihistamines may suppress the skin test response. - Beta‑blockers may increase the risk of severe anaphylaxis and reduce response to epinephrine.

Moderate Interactions (Monitor Closely): - ACE inhibitors may potentiate angioedema. - Recent immunotherapy may alter test reactivity. - Topical corticosteroids applied to the test area may reduce wheal formation.